AGTR1 and Cognitive impairment: Moreover, Zhuang et al. showed in their meta-analysis that ACE inhibitors, as well as AT1R blockade, lowered the risk of AD, and AT1R blockade additionally decreased the risk of cognitive impairment associated with age [90].